172 related articles for article (PubMed ID: 9927130)
1. Prognostic factors in T1 and T2 squamous cell carcinoma of the thoracic esophagus.
Tachibana M; Kinugasa S; Dhar DK; Tabara H; Masunaga R; Kotoh T; Kubota H; Nagasue N
Arch Surg; 1999 Jan; 134(1):50-4. PubMed ID: 9927130
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors in node-negative squamous cell carcinoma of the thoracic esophagus.
Tachibana M; Kinugasa S; Dhar DK; Shibakita M; Ohno S; Masunaga R; Kotoh T; Kubota H; Nagasue N
Int J Surg Investig; 2000; 1(5):389-95. PubMed ID: 11341595
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors after extended esophagectomy for squamous cell carcinoma of the thoracic esophagus.
Tachibana M; Kinugasa S; Dhar DK; Kotoh T; Shibakita M; Ohno S; Masunaga R; Kubota H; Kohno H; Nagasue N
J Surg Oncol; 1999 Oct; 72(2):88-93. PubMed ID: 10518105
[TBL] [Abstract][Full Text] [Related]
4. Prognostic evaluation for squamous cell carcinomas of the lower thoracic esophagus treated with three-field lymph node dissection.
Igaki H; Kato H; Tachimori Y; Sato H; Daiko H; Nakanishi Y
Eur J Cardiothorac Surg; 2001 Jun; 19(6):887-93. PubMed ID: 11404147
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of perioperative blood transfusions in resectable thoracic esophageal cancer.
Tachibana M; Tabara H; Kotoh T; Kinugasa S; Dhar DK; Hishikawa Y; Masunaga R; Kubota H; Nagasue N
Am J Gastroenterol; 1999 Mar; 94(3):757-65. PubMed ID: 10086663
[TBL] [Abstract][Full Text] [Related]
6. Outcome of histologically node-negative esophageal squamous cell carcinoma.
Tabira Y; Yasunaga M; Sakaguchi T; Yamaguchi Y; Okuma T; Kawasuji M
World J Surg; 2002 Dec; 26(12):1446-51. PubMed ID: 12297913
[TBL] [Abstract][Full Text] [Related]
7. Prognostic evaluation of patients with clinical T1 and T2 squamous cell carcinomas of the thoracic esophagus after 3-field lymph node dissection.
Igaki H; Kato H; Tachimori Y; Nakanishi Y
Surgery; 2003 Apr; 133(4):368-74. PubMed ID: 12717353
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic characteristics and survival of patients with clinical Stage I squamous cell carcinomas of the thoracic esophagus treated with three-field lymph node dissection.
Igaki H; Kato H; Tachimori Y; Daiko H; Fukaya M; Yajima S; Nakanishi Y
Eur J Cardiothorac Surg; 2001 Dec; 20(6):1089-94. PubMed ID: 11717009
[TBL] [Abstract][Full Text] [Related]
9. Nodal skip metastasis in thoracic esophageal squamous cell carcinoma: a cohort study.
Cavallin F; Alfieri R; Scarpa M; Cagol M; Ruol A; Fassan M; Rugge M; Ancona E; Castoro C
BMC Surg; 2017 May; 17(1):49. PubMed ID: 28464907
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the 7th edition of the TNM classification in patients with resected esophageal squamous cell carcinoma.
Wang J; Wu N; Zheng QF; Yan S; Lv C; Li SL; Yang Y
World J Gastroenterol; 2014 Dec; 20(48):18397-403. PubMed ID: 25561808
[TBL] [Abstract][Full Text] [Related]
11. Predictors of Lymph Node Metastasis in Surgically Resected T1 Esophageal Cancer.
Dubecz A; Kern M; Solymosi N; Schweigert M; Stein HJ
Ann Thorac Surg; 2015 Jun; 99(6):1879-85; discussion 1886. PubMed ID: 25929888
[TBL] [Abstract][Full Text] [Related]
12. [Predictive value of log odds of positive lymph nodes for the prognosis of patients with node-negative squamous cell carcinoma of the thoracic esophagus after radical esophagectomy].
Yang M; Zhang H; Huo X; Chen C; Yu Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 May; 19(5):535-9. PubMed ID: 27215521
[TBL] [Abstract][Full Text] [Related]
13. Esophageal cancer with distant lymph node metastasis: prognostic significance of metastatic lymph node ratio.
Tachibana M; Dhar DK; Kinugasa S; Kotoh T; Shibakita M; Ohno S; Masunaga R; Kubota H; Nagasue N
J Clin Gastroenterol; 2000 Dec; 31(4):318-22. PubMed ID: 11129274
[TBL] [Abstract][Full Text] [Related]
14. Stage II esophageal carcinoma: the significance of T and N.
Killinger WA; Rice TW; Adelstein DJ; Medendorp SV; Zuccaro G; Kirby TJ; Goldblum JR
J Thorac Cardiovasc Surg; 1996 May; 111(5):935-40. PubMed ID: 8622316
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic Features of Submucosal Esophageal Squamous Cell Carcinoma.
Emi M; Hihara J; Hamai Y; Furukawa T; Ibuki Y; Okada M
Ann Thorac Surg; 2017 Dec; 104(6):1858-1864. PubMed ID: 29033014
[TBL] [Abstract][Full Text] [Related]
16. Prognosis of Patients With Pathologic T0 N+ Esophageal Squamous Cell Carcinoma After Chemoradiotherapy and Surgical Resection: Results From a Nationwide Study.
Chao YK; Chen HS; Wang BY; Hsu PK; Liu CC; Wu SC
Ann Thorac Surg; 2016 May; 101(5):1897-902. PubMed ID: 26912307
[TBL] [Abstract][Full Text] [Related]
17. [Survival analysis of patients with stage II squamous cell carcinoma of the thoracic esophagus after esophagectomy].
Zhang DK; Su XD; Lin P
Ai Zheng; 2008 Feb; 27(2):113-8. PubMed ID: 18279605
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of subcarinal lymph node metastasis in patients with esophageal squamous cell carcinoma.
Feng JF; Zhao Q; Chen QX
Asian Pac J Cancer Prev; 2013; 14(5):3183-6. PubMed ID: 23803101
[TBL] [Abstract][Full Text] [Related]
19. Esophageal cancer patients surviving 6 years after esophagectomy.
Tachibana M; Dhar DK; Kinugasa S; Yoshimura H; Fujii T; Shibakita M; Ohno S; Ueda S; Kohno H; Nagasue N
Langenbecks Arch Surg; 2002 Jun; 387(2):77-83. PubMed ID: 12111259
[TBL] [Abstract][Full Text] [Related]
20. Significance of three-field lymphadenectomy for carcinoma of the thoracic esophagus based on depth of tumor infiltration, lymph nodal involvement and survival rate.
Tabira Y; Kitamura N; Yoshioka M; Tanaka M; Nakano K; Toyota N; Mori T
J Cardiovasc Surg (Torino); 1999 Oct; 40(5):737-40. PubMed ID: 10597014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
